[144] Cellebrite DI Ltd. Warrants SEC Filing

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBTW) Form 144 notifies the market of a proposed sale of 37,965 common shares through Morgan Stanley Smith Barney LLC on 08/25/2025. The filing reports an aggregate market value of $608,243.80 for the shares and shows 244,469,106 shares outstanding for the issuer. Acquisition details in the form indicate the shares were obtained as restricted stock on 08/14/2024, 11/14/2024, 02/14/2025, and 05/14/2025 (amounts 3,587; 5,497; 5,497; 5,497 respectively) and via a stock option exercise on 08/25/2025 (17,887 shares, paid in cash). The filer reports no securities sold in the past three months. The notice includes the standard representation that the person signing does not possess undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing an insider-proposed sale; transaction details and acquisition dates are fully disclosed.

The filing is a standard Rule 144 notice indicating an intended brokered sale of common shares through Morgan Stanley Smith Barney LLC on August 25, 2025. It provides clear acquisition history showing restricted stock grants and an option exercise as the sources of the shares to be sold. The filing also confirms no sales in the prior three months and includes the signature representation regarding undisclosed material information. For investors, this is a transparency disclosure rather than an operational update.

Corporate Governance Expert

TL;DR: Disclosure aligns with regulatory requirements; it documents insider sales sources and affirms no undisclosed material facts.

The Form 144 supplies the necessary compliance details: broker identity, share counts, market value, and acquisition provenance (restricted stock and option exercise). It also contains the attestation about material information and a declaration of no recent sales by the filer in the prior three months. This filing meets procedural disclosure expectations under Rule 144 but does not by itself indicate governance changes or new corporate actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	37965	608243.80	244469106	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2024	Restricted Stock	ISSUER			3587	08/14/2024	Not Applicable
Common	02/14/2025	Restricted Stock	ISSUER			5497	02/14/2025	Not Applicable
Common	11/14/2024	Restricted Stock	ISSUER			5497	11/14/2024	Not Applicable
Common	05/14/2025	Restricted Stock	ISSUER			5497	05/14/2025	Not Applicable
Common	08/25/2025	Stock Option Exercise	ISSUER			17887	08/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)